Current radiopharmaceuticals最新文献

筛选
英文 中文
Protective Effects of Alpha-lipoic Acid, Resveratrol, and Apigenin Against Oxidative Damages, Histopathological Changes, and Mortality Induced by Lung Irradiation in Rats. α-硫辛酸、白藜芦醇和芹菜素对肺辐射诱导的大鼠氧化损伤、组织病理学变化和死亡率的保护作用。
IF 2.3 4区 医学
Current radiopharmaceuticals Pub Date : 2024-01-01 DOI: 10.2174/0118744710244357231018070313
Nasrin Seyedpour, Elahe Motevaseli, Shahram Taeb, Azin Nowrouzi, Fatemeh Mirzaei, Mina Bahri, Hamid Reza Dehghan-Manshadi, Mohsen Zhaleh, Khodabakhsh Rashidi, Rasool Azmoonfar, Rasoul Yahyapour, Masoud Najafi
{"title":"Protective Effects of Alpha-lipoic Acid, Resveratrol, and Apigenin Against Oxidative Damages, Histopathological Changes, and Mortality Induced by Lung Irradiation in Rats.","authors":"Nasrin Seyedpour, Elahe Motevaseli, Shahram Taeb, Azin Nowrouzi, Fatemeh Mirzaei, Mina Bahri, Hamid Reza Dehghan-Manshadi, Mohsen Zhaleh, Khodabakhsh Rashidi, Rasool Azmoonfar, Rasoul Yahyapour, Masoud Najafi","doi":"10.2174/0118744710244357231018070313","DOIUrl":"10.2174/0118744710244357231018070313","url":null,"abstract":"<p><strong>Aim: </strong>This study investigated the protective effects of three antioxidants on radiationinduced lung injury.</p><p><strong>Background: </strong>Oxidative stress is one of the key outcomes of radiotherapy in normal tissues. It can induce severe injuries in lung tissue, which may lead to pneumonitis and fibrosis. Recently, interest in natural chemicals as possible radioprotectors has increased due to their reduced toxicity, cheaper price, and other advantages.</p><p><strong>Objective: </strong>The present study was undertaken to evaluate the radioprotective effect of Alpha-lipoic Acid (LA), Resveratrol (RVT), and Apigenin (APG) against histopathological changes and oxidative damage and survival induced by ionizing radiation (IR) in the lung tissues of rats.</p><p><strong>Methods: </strong>First, the lung tissue of 50 mature male Wistar rats underwent an 18 Gy gamma irradiation. Next, the rats were sacrificed and transverse sections were obtained from the lung tissues and stained with hematoxylin and eosin (H and E) and Mason trichrome (MTC) for histopathological evaluation. Then, the activity of Glutathione peroxidase (GPx), Superoxide Dismutase (SOD), and Malondialdehyde (MDA) was measured by an ELISA reader at 340, 405, and 550 nm.</p><p><strong>Results: </strong>Based on the results of this study, IR led to a remarkable increase in morphological changes in the lung. However, APG, RVT, and LA could ameliorate the deleterious effects of IR in lung tissue. IR causes an increase in GPX level, and APG+IR administration causes a decrease in the level of GPX compared to the control group. Also, the results of this study showed that RVT has significant effects in reducing MDA levels in the short term. In addition, compared to the control group, IR and RVT+IR decrease the activity of SOD in the long term in the lung tissues of rats. Also, the analysis of results showed that weight changes in IR, LA+IR, APG+IR, and control groups were statistically significant.</p><p><strong>Conclusion: </strong>APG and RVT could prevent tissue damage induced by radiation effects in rat lung tissues. Hence, APG, LA, and RVT could provide a novel preventive action with their potential antioxidant anti-inflammatory properties, as well as their great safety characteristic.</p>","PeriodicalId":10991,"journal":{"name":"Current radiopharmaceuticals","volume":" ","pages":"99-110"},"PeriodicalIF":2.3,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71421606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current Advancement and Future Prospects: Biomedical Nanoengineering. 生物医学纳米工程的现状与展望。
IF 1.5 4区 医学
Current radiopharmaceuticals Pub Date : 2024-01-01 DOI: 10.2174/0118744710274376231123063135
Sonia Singh, Hrishika Sahani
{"title":"Current Advancement and Future Prospects: Biomedical Nanoengineering.","authors":"Sonia Singh, Hrishika Sahani","doi":"10.2174/0118744710274376231123063135","DOIUrl":"10.2174/0118744710274376231123063135","url":null,"abstract":"<p><p>Recent advancements in biomedicine have seen a significant reliance on nanoengineering, as traditional methods often fall short in harnessing the unique attributes of biomaterials. Nanoengineering has emerged as a valuable approach to enhance and enrich the performance and functionalities of biomaterials, driving research and development in the field. This review emphasizes the most prevalent biomaterials used in biomedicine, including polymers, nanocomposites, and metallic materials, and explores the pivotal role of nanoengineering in developing biomedical treatments and processes. Particularly, the review highlights research focused on gaining an in-depth understanding of material properties and effectively enhancing material performance through molecular dynamics simulations, all from a nanoengineering perspective.</p>","PeriodicalId":10991,"journal":{"name":"Current radiopharmaceuticals","volume":" ","pages":"120-137"},"PeriodicalIF":1.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138498055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimal Indications of Radioimmunotherapy in Nuclear Medicine: A Mini-Review. 核医学中放射免疫疗法的最佳适应症:微型综述
IF 1.5 4区 医学
Current radiopharmaceuticals Pub Date : 2024-01-01 DOI: 10.2174/0118744710295825240308093429
Nasim Vahidfar, Hojjat Ahmadzadehfar, Saeed Farzanefar, Mehrshad Abbasi, Yalda Salehi, Fateme Saboktakin, Mahsa Jahanbin, Mohsen Bakhshi Kashi, Elisabeth Eppard, Hans Jürgen Biersack
{"title":"Optimal Indications of Radioimmunotherapy in Nuclear Medicine: A Mini-Review.","authors":"Nasim Vahidfar, Hojjat Ahmadzadehfar, Saeed Farzanefar, Mehrshad Abbasi, Yalda Salehi, Fateme Saboktakin, Mahsa Jahanbin, Mohsen Bakhshi Kashi, Elisabeth Eppard, Hans Jürgen Biersack","doi":"10.2174/0118744710295825240308093429","DOIUrl":"10.2174/0118744710295825240308093429","url":null,"abstract":"<p><p>Immunotherapy has emerged as a very considerable and potent therapeutic method in which immune inhibitors have gained a lot of attention in the curative field of various cancers. Under certain circumstances, when radiotherapy is accompanied by immunotherapy, the efficacy of the therapeutic procedure increases. Irradiated tumor cells follow a pathway called immunogenic cell death, which targets tumor associated antigens. The application of radiolabeled antibodies under the concept of \"radioimmunotherapy\" (RIT) makes the synergistic targeted therapeutic effect possible. Since antibodies themselves are cytotoxic, they can kill the cells that not only bind but are within the path length of their radiation emissions. RIT can be categorized as a substantial progress in nuclear medicine. The main concept of RIT includes targeting specified tumor-expressing antibodies. The mentioned purpose is achievable by formulation of radiolabeled antibodies, which could be injected intravenously or directly into the tumor, as well as compartmentally into a body cavity such as the peritoneum, pleura, or intrathecal space. RIT has demonstrated very optimistic therapeutic outcomes in radioresistant solid tumors. Wide ranges of efforts are accomplished in order to improve clinical trial accomplishments. In this review, we intend to summarize the performed studies on RIT and their importance in medicine.</p>","PeriodicalId":10991,"journal":{"name":"Current radiopharmaceuticals","volume":" ","pages":"320-329"},"PeriodicalIF":1.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140174025","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
RGIE: A Gene Selection Method Related to Radiotherapy Resistance in Head and Neck Squamous Cell Carcinoma. RGIE:一种与头颈部鳞状细胞癌放疗耐药性相关的基因筛选方法。
IF 1.5 4区 医学
Current radiopharmaceuticals Pub Date : 2024-01-01 DOI: 10.2174/0118744710282465240315053136
Qingzhe Meng, Dunhui Liu, Junhong Huang, Xinjie Yang, Huan Li, Zihui Yang, Jun Wang, Wanpeng Gao, Yahui Li, Rong Liu, Liying Yang, Jianhua Wei
{"title":"RGIE: A Gene Selection Method Related to Radiotherapy Resistance in Head and Neck Squamous Cell Carcinoma.","authors":"Qingzhe Meng, Dunhui Liu, Junhong Huang, Xinjie Yang, Huan Li, Zihui Yang, Jun Wang, Wanpeng Gao, Yahui Li, Rong Liu, Liying Yang, Jianhua Wei","doi":"10.2174/0118744710282465240315053136","DOIUrl":"10.2174/0118744710282465240315053136","url":null,"abstract":"<p><strong>Background: </strong>Head and Neck Squamous Cell Carcinoma (HNSCC) is a malignant tumor with a high degree of malignancy, invasiveness, and metastasis rate. Radiotherapy, as an important adjuvant therapy for HNSCC, can reduce the postoperative recurrence rate and improve the survival rate. Identifying the genes related to HNSCC radiotherapy resistance (HNSCC-RR) is helpful in the search for potential therapeutic targets. However, identifying radiotherapy resistance-related genes from tens of thousands of genes is a challenging task. While interactions between genes are important for elucidating complex biological processes, the large number of genes makes the computation of gene interactions infeasible.</p><p><strong>Methods: </strong>We propose a gene selection algorithm, RGIE, which is based on ReliefF, Gene Network Inference with Ensemble of Trees (GENIE3) and Feature Elimination. ReliefF was used to select a feature subset that is discriminative for HNSCC-RR, GENIE3 constructed a gene regulatory network based on this subset to analyze the regulatory relationship among genes, and feature elimination was used to remove redundant and noisy features.</p><p><strong>Results: </strong>Nine genes (SPAG1, FIGN, NUBPL, CHMP5, TCF7L2, COQ10B, BSDC1, ZFPM1, GRPEL1) were identified and used to identify HNSCC-RR, which achieved performances of 0.9730, 0.9679, 0.9767, and 0.9885 in terms of accuracy, precision, recall, and AUC, respectively. Finally, qRT-PCR validated the differential expression of the nine signature genes in cell lines (SCC9, SCC9-RR).</p><p><strong>Conclusion: </strong>RGIE is effective in screening genes related to HNSCC-RR. This approach may help guide clinical treatment modalities for patients and develop potential treatments.</p>","PeriodicalId":10991,"journal":{"name":"Current radiopharmaceuticals","volume":" ","pages":"341-355"},"PeriodicalIF":1.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140293119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Performance of Iron Phosphate Glass Containing Various Heavy Metal Oxides for Particulate Nuclear Radiation Shielding. 含各种重金属氧化物的磷酸铁玻璃在核辐射微粒屏蔽中的性能。
IF 1.5 4区 医学
Current radiopharmaceuticals Pub Date : 2024-01-01 DOI: 10.2174/0118744710271477231105075516
Bassem Abdelwahab, G S M Ahmed, M El-Ghazaly, A Zoulfakar, S M Salem, I I Bashter, A G Mostafa
{"title":"Performance of Iron Phosphate Glass Containing Various Heavy Metal Oxides for Particulate Nuclear Radiation Shielding.","authors":"Bassem Abdelwahab, G S M Ahmed, M El-Ghazaly, A Zoulfakar, S M Salem, I I Bashter, A G Mostafa","doi":"10.2174/0118744710271477231105075516","DOIUrl":"10.2174/0118744710271477231105075516","url":null,"abstract":"<p><strong>Background: </strong>Employees may be exposed to different kinds of ionizing radiation at work. When ionizing radiation interacts with human cells, it can cause damage to the cells and genetic material. Therefore, one of the scientists' primary objectives has always been to create the best radiation-shielding materials. Glass could offer promising shielding material resulting from the high flexibility of composition, simplicity of production, and good thermal stability.</p><p><strong>Materials and methods: </strong>The melt-quenching technique was used to create a glass having the following formula: 50% P<sub>2</sub>O<sub>5</sub>+20% Na<sub>2</sub>O+20% Fe<sub>2</sub>O<sub>3</sub>+10% X, where X = As<sub>2</sub>O<sub>3</sub>, SrO, BaO, CdO, and Sb<sub>2</sub>O<sub>3</sub> mol %. The impact of the different heavy metal additions on the structure of the glass networks was studied using FTIR spectroscopy. Glass's ability to attenuate neutrons and/or charged particles has been theoretically investigated. The performance of the developed glass as a shield was examined by a comparison against commercial glass (RS 253 G18), ordinary concrete (OC), and water (H<sub>2</sub>O).</p><p><strong>Results: </strong>For charged particle radiations (Electrons, Protons, and Alpha), the shielding parameters like the mass stopping power, the projected range, and the effective atomic number were evaluated, where S5/Sb glass achieves the best performance. In the case of Neutrons, the results values reveal that S3/Ba glass ( Σ<sub>R</sub> = 0.105) is the best-modified glass for neutron shielding.</p><p><strong>Conclusion: </strong>Among all the investigated glasses, S5/Sb glass composition has a smaller range and provides superior protection against charged particles. In contrast, the S3/Ba glass composition is a superior choice for shielding against neutron radiation.</p>","PeriodicalId":10991,"journal":{"name":"Current radiopharmaceuticals","volume":" ","pages":"247-256"},"PeriodicalIF":1.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139402264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radiopharmaceuticals: A New Vista for Diagnosis and Treatment of Thyroid Cancer. 放射性药物:诊断和治疗甲状腺癌的新方法
IF 1.5 4区 医学
Current radiopharmaceuticals Pub Date : 2024-01-01 DOI: 10.2174/0118744710277275231112081003
Siddhi Vernekar, Roja Rani Budha, Rajasekhar Reddy Alavala
{"title":"Radiopharmaceuticals: A New Vista for Diagnosis and Treatment of Thyroid Cancer.","authors":"Siddhi Vernekar, Roja Rani Budha, Rajasekhar Reddy Alavala","doi":"10.2174/0118744710277275231112081003","DOIUrl":"10.2174/0118744710277275231112081003","url":null,"abstract":"<p><p>Radiopharmaceuticals are in the diagnosis and treatment of cancerous and noncancerous diseases, and a hope for optimistic effort in the field of nuclear medicine. They play a crucial role in clinical nuclear medicine by providing a tool to comprehend human disease and create efficient treatments. A detailed analysis is provided regarding the crux of molecular imaging including PET and SPECT overview for the detection of cancers. For a specified understanding of radiation therapy, topics include ranging from the selection of radionuclide to its development and manufacture, and dosage requirements to establishing the importance of I- 131 Radiotherapy in thyroid cancer. In this review, we also discussed the current state of the art of nuclear medicine in thyroid cancer, including the role of radioiodine (RAI) therapeutic scans in the diagnosis of differentiated thyroid cancer. In addition, we established a brief outlook into the current status of the research in thyroid cancer and discussed the future directions in this field.</p>","PeriodicalId":10991,"journal":{"name":"Current radiopharmaceuticals","volume":" ","pages":"148-162"},"PeriodicalIF":1.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139424421","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radioprotective Effect of Piperine, as a Major Component of Black Pepper, Against Radiation-induced Colon Injury: Biochemical and Histological Studies. 黑胡椒的主要成分胡椒碱对辐射引起的结肠损伤的辐射防护作用:生化和组织学研究。
IF 2.3 4区 医学
Current radiopharmaceuticals Pub Date : 2024-01-01 DOI: 10.2174/1874471016666230725112319
Asal Safarbalou, Fatemeh Ebrahimi, Fereshteh Talebpour Amiri, Seyed Jalal Hosseinimehr
{"title":"Radioprotective Effect of Piperine, as a Major Component of Black Pepper, Against Radiation-induced Colon Injury: Biochemical and Histological Studies.","authors":"Asal Safarbalou, Fatemeh Ebrahimi, Fereshteh Talebpour Amiri, Seyed Jalal Hosseinimehr","doi":"10.2174/1874471016666230725112319","DOIUrl":"10.2174/1874471016666230725112319","url":null,"abstract":"<p><strong>Background: </strong>Patients undergoing radiotherapy are prone to radiation-induced gastrointestinal injury. Piperine is an alkaloid component in black pepper with a unique chemopreventive activity against oxidative stress-related damage in healthy tissues. The purpose of this study was to investigate the effects of piperine on intestinal damage.</p><p><strong>Methods: </strong>In this study, mice were divided into eight groups: including the control, piperine (10, 25, and 50 mg/kg), radiation (6 Gy), and piperine+radiation (10, 25 and 50 mg/kg + 6 Gy) groups. The radioprotective effects of piperine were evaluated by biochemical (MDA, GSH, and PC) and histopathological assessments in colon tissues.</p><p><strong>Results: </strong>The 10 mg/kg dose of piperine significantly reduced the levels of oxidative stress biomarkers compared to the group that received only radiation. In addition, pre-treatment with 10 mg/kg piperine diminished the histopathological changes like vascular congestion in the submucosa, while the dose of 50 mg/kg led to the infiltration of inflammatory cells.</p><p><strong>Conclusion: </strong>Based on this study, it is concluded that piperine, at low dose, with its antioxidant properties, could reduce the colon damage caused by radiation.</p>","PeriodicalId":10991,"journal":{"name":"Current radiopharmaceuticals","volume":" ","pages":"38-45"},"PeriodicalIF":2.3,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9866237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Design of a New 99mTc-radiolabeled Cyclo-peptide as Promising Molecular Imaging Agent of CXCR4 Receptor: Molecular Docking, Synthesis, Radiolabeling, and Biological Evaluation. 一种新的99mTc放射性标记环肽作为CXCR4受体有前途的分子显像剂的设计:分子对接、合成、放射性标记和生物学评价。
IF 1.5 4区 医学
Current radiopharmaceuticals Pub Date : 2024-01-01 DOI: 10.2174/0118744710249305231017073022
Leila Hassanzadeh, Mostafa Erfani, Safura Jokar, Marjan Shariatpanahi
{"title":"Design of a New <sup>99m</sup>Tc-radiolabeled Cyclo-peptide as Promising Molecular Imaging Agent of CXCR<sub>4</sub> Receptor: Molecular Docking, Synthesis, Radiolabeling, and Biological Evaluation.","authors":"Leila Hassanzadeh, Mostafa Erfani, Safura Jokar, Marjan Shariatpanahi","doi":"10.2174/0118744710249305231017073022","DOIUrl":"10.2174/0118744710249305231017073022","url":null,"abstract":"<p><strong>Introduction: </strong>C-X-C Chemokine receptor type 4 (CXCR4) is often overexpressed or overactivated in different types and stages of cancer disease. Therefore, it is considered a promising target for imaging and early detection of primary tumors and metastasis. In the present research, a new cyclo-peptide radiolabelled with <sup>99m</sup>Tc, <sup>99m</sup>Tc-Cyclo [D-Phe-D-Tyr-Lys (HYNIC)- D-Arg-2-Nal-Gly-Lys(iPr)], was designed based on the parental LY251029 peptide, as a potential <i>in vivo</i> imaging agent of CXCR4-expressing tumors.</p><p><strong>Methods: </strong>The radioligand was successfully prepared using the method of Fmoc solid-phase peptide synthesis and was evaluated in biological assessment. Molecular docking findings revealed high affinity (binding energy of -9.7 kcal/mol) and effective interaction of Cyclo [D-Phe- D-Tyr-Lys (HYNIC)-D-Arg-2-Nal-Gly-Lys(iPr)] in the binding pocket of CXCR4 receptor (PDB code: 3OE0) as well.</p><p><strong>Result: </strong>The synthesized peptide and its purity were assessed by both reversed-phase high-performance liquid chromatography (RP-HPLC) and mass spectroscopy. High stability (95%, n = 3) in human serum and favorable affinity (Kd = 28.70 ± 13.56 nM and Bmax = 1.896 ± 0.123 fmol/mg protein) in the B16-F10 cell line resulted. Biodistribution evaluation findings and planar image interpretation of mice both showed high affinity and selectivity of the radiotracer to the CXCR4 receptors.</p><p><strong>Conclusion: </strong>Therefore, the findings indicate this designed radioligand could be used as a potential SPECT imaging agent in highly proliferated CXCR4 receptor tumors.</p>","PeriodicalId":10991,"journal":{"name":"Current radiopharmaceuticals","volume":" ","pages":"77-90"},"PeriodicalIF":1.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71421605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Radioprotective Effect of LBP on Neurogenesis and Cognition after Acute Radiation Exposure. 枸杞多糖对急性辐射暴露后神经发生和认知的辐射保护作用
IF 1.5 4区 医学
Current radiopharmaceuticals Pub Date : 2024-01-01 DOI: 10.2174/0118744710274008231220055033
Gang Yin, Qinqi Wang, Tongtong Lv, Yifan Liu, Xiaochun Peng, Xianqin Zeng, Jiangrong Huang
{"title":"The Radioprotective Effect of LBP on Neurogenesis and Cognition after Acute Radiation Exposure.","authors":"Gang Yin, Qinqi Wang, Tongtong Lv, Yifan Liu, Xiaochun Peng, Xianqin Zeng, Jiangrong Huang","doi":"10.2174/0118744710274008231220055033","DOIUrl":"10.2174/0118744710274008231220055033","url":null,"abstract":"<p><strong>Background: </strong>Radiation exposure has been linked to the development of brain damage and cognitive impairment, but the protective effect and mechanism of Lycium barbarum pills (LBP) on radiation-induced neurological damage remains to be clarified.</p><p><strong>Methods: </strong>Behavioral tests and immunohistochemical studies were conducted to evaluate the protective effects of LBP extract (10 g/kg orally daily for 4 weeks) against radiation-induced damage on neurogenesis and cognitive function in Balb/c mice exposed to 5.5 Gy X-ray acute radiation.</p><p><strong>Results: </strong>The results showed that the LBP extract significantly improved body weight loss, locomotor activity and spatial learning and memory. Immunohistochemical tests revealed that the LBP extract prevented the loss of proliferating cells, newly generated neurons and interneurons, especially in the subgranular area of the dentate gyrus.</p><p><strong>Conclusion: </strong>The findings suggest that LBP is a potential neuroprotective drug for mitigating radiation-induced neuropsychological disorders.</p>","PeriodicalId":10991,"journal":{"name":"Current radiopharmaceuticals","volume":" ","pages":"257-265"},"PeriodicalIF":1.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11327742/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139416639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
"One Method to Label Them All": A Single Fully Automated Protocol for GMP-Compliant 68Ga Radiolabeling of PSMA-11, Transposable to PSMA-I&T and PSMA-617. "一种方法标记所有":符合 GMP 标准的 PSMA-11 68Ga 放射性标记全自动单一方案,可转用 PSMA-I&T 和 PSMA-617。
IF 1.5 4区 医学
Current radiopharmaceuticals Pub Date : 2024-01-01 DOI: 10.2174/0118744710293461240219111852
Juliette Fouillet, Charlotte Donzé, Emmanuel Deshayes, Lore Santoro, Léa Rubira, Cyril Fersing
{"title":"\"One Method to Label Them All\": A Single Fully Automated Protocol for GMP-Compliant <sup>68</sup>Ga Radiolabeling of PSMA-11, Transposable to PSMA-I&T and PSMA-617.","authors":"Juliette Fouillet, Charlotte Donzé, Emmanuel Deshayes, Lore Santoro, Léa Rubira, Cyril Fersing","doi":"10.2174/0118744710293461240219111852","DOIUrl":"10.2174/0118744710293461240219111852","url":null,"abstract":"<p><strong>Background: </strong>Prostate-specific membrane antigen (PSMA) is an ideal target for molecular imaging and targeted radionuclide therapy in prostate cancer. Consequently, various PSMA ligands were developed. Some of these molecules are functionalized with a chelator that can host radiometals, such as <sup>68</sup>Ga for PET imaging. The <sup>68</sup>Ga radiolabeling step benefits from process automation, making it more robust and reducing radiation exposure.</p><p><strong>Objective: </strong>To design a single automated radiolabeling protocol for the GMP-compliant preparation of [<sup>68</sup>Ga]Ga-PSMA-11, transposable to the production of [<sup>68</sup>Ga]Ga-PSMA-617 and [<sup>68</sup>Ga]Ga-PSMA-I&T.</p><p><strong>Methods: </strong>A GAIA<sup>®</sup> synthesis module and a GALLIAD<sup>®</sup> generator were used. Radio-TLC and radio-HPLC methods were validated for radiochemical purity (RCP) determination. Three [<sup>68</sup>Ga]Ga-PSMA-11 validation batches were produced and thoroughly tested for appearance and pH, radionuclide identity and purity, RCP, stability, residual solvent and sterility. Minimal modifications were made to the reagents and disposables for optimal application to other PSMA ligands.</p><p><strong>Results: </strong>[<sup>68</sup>Ga]Ga-PSMA-11 for clinical application was produced in 27 min. The 3 validation batches met the quality criteria expected by the European Pharmacopoeia to allow routine production. For optimal transposition to PSMA-617, the solid phase extraction cartridge was changed to improve purification of the radiolabeled product. For application to PSMA-I&T, the buffer solution initially used was replaced by HEPES 2.7 M to achieve good radiochemical yields. Residual HEPES content was checked in the final product and was below the Ph. Eur. threshold.</p><p><strong>Conclusion: </strong>A single automated radiolabeling method on the GAIA<sup>®</sup> module was developed and implemented for <sup>68</sup>Ga radiolabeling of 3 PSMA ligands, with slight adjustments for each molecule.</p>","PeriodicalId":10991,"journal":{"name":"Current radiopharmaceuticals","volume":" ","pages":"285-301"},"PeriodicalIF":1.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11348474/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139995834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信